NEUMORA THERAPEUTICS, INC.: 10-Q filed 2025-08-06
What NEUMORA THERAPEUTICS, INC. reported in its quarterly report filed 2025-08-06 (fiscal Q2 2025): 37 published measures, 108 facts as tagged in accession 0000950170-25-104138.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2025-08-06
- Fiscal period
- fiscal Q2 2025
- Accession
- 0000950170-25-104138 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NEUMORA THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 223,825,000 | USD | |
| At 2024-12-31 | 316,972,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 40,946,000 | USD | |
| At 2024-12-31 | 29,908,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 182,879,000 | USD | |
| At 2025-03-31 | 228,364,000 | USD | |
| At 2024-12-31 | 287,064,000 | USD | |
| At 2024-06-30 | 381,259,000 | USD | |
| At 2024-03-31 | 424,542,000 | USD | |
| At 2023-12-31 | 469,076,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 124,523,000 | USD | |
| At 2024-12-31 | 142,148,000 | USD | |
| At 2024-06-30 | 150,678,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -52,731,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -120,723,000 | USD | 181 |
| 2025-01-01 to 2025-03-31 | -67,992,000 | USD | 90 |
| 2024-04-01 to 2024-06-30 | -58,700,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -112,421,000 | USD | 182 |
| 2024-01-01 to 2024-03-31 | -53,721,000 | USD | 91 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | -111,852,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | -99,113,000 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 18,457,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 4,499,000 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 74,557,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | -128,746,000 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | -1,067,944,000 | USD | |
| At 2024-12-31 | -947,221,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 161,691,000 | shares | 91 |
| 2025-01-01 to 2025-06-30 | 161,572,000 | shares | 181 |
| 2024-04-01 to 2024-06-30 | 158,984,000 | shares | 91 |
| 2024-01-01 to 2024-06-30 | 158,464,000 | shares | 182 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 161,691,000 | shares | 91 |
| 2025-01-01 to 2025-06-30 | 161,572,000 | shares | 181 |
| 2024-04-01 to 2024-06-30 | 158,984,000 | shares | 91 |
| 2024-01-01 to 2024-06-30 | 158,464,000 | shares | 182 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -0.33 | USD/shares | 91 |
| 2025-01-01 to 2025-06-30 | -0.75 | USD/shares | 181 |
| 2024-04-01 to 2024-06-30 | -0.37 | USD/shares | 91 |
| 2024-01-01 to 2024-06-30 | -0.71 | USD/shares | 182 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -0.33 | USD/shares | 91 |
| 2025-01-01 to 2025-06-30 | -0.75 | USD/shares | 181 |
| 2024-04-01 to 2024-06-30 | -0.37 | USD/shares | 91 |
| 2024-01-01 to 2024-06-30 | -0.71 | USD/shares | 182 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 25,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 130,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 125,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 125,000 | USD | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 87,000 | USD | |
| At 2024-12-31 | 1,140,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 16,489,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 20,141,000 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -54,040,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -124,976,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | -63,822,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -123,896,000 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 222,909,000 | USD | |
| At 2024-12-31 | 314,055,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 21,156,000 | USD | |
| At 2024-12-31 | 29,886,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 644,000 | USD | |
| At 2024-12-31 | 3,307,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 54,040,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 124,976,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 63,822,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 123,896,000 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 38,724,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 90,875,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 48,628,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 94,385,000 | USD | 182 |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | -15,000 | USD | |
| At 2024-12-31 | 62,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 531,000 | USD | |
| At 2024-12-31 | 1,777,000 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 19,451,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 298,000 | USD | |
| At 2024-12-31 | 0 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 20,253,000 | USD | |
| At 2024-12-31 | 24,593,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-06-30 | 5,321,000 | USD | |
| At 2024-12-31 | 5,264,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -52,706,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -120,593,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | -58,575,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -112,296,000 | USD | 182 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | -120,723,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | -112,421,000 | USD | 182 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -52,743,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -120,800,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | -58,739,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -112,532,000 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 15,316,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 34,101,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 15,194,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 29,511,000 | USD | 182 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 176,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 318,000 | USD | 182 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | -480,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -505,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | -24,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | -36,000 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 1,334,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 4,383,000 | USD | 181 |
| 2024-04-01 to 2024-06-30 | 5,247,000 | USD | 91 |
| 2024-01-01 to 2024-06-30 | 11,600,000 | USD | 182 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 134,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 0 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | -2,663,000 | USD | 181 |
| 2024-01-01 to 2024-06-30 | 745,000 | USD | 182 |
Inspect the source
- Entity
- NEUMORA THERAPEUTICS, INC. / CIK 0001885522
- Captured
- 2026-09-21T17:33:04.919Z
- SEC response SHA-256
744d61a9d79a54eed83a2f1a976860f50e18dad7263c747c141007a85fc8f73d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001885522.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))